Skip to main content
Clinical Trials/NCT03532724
NCT03532724CompletedNot Applicable

Retrospective Analysis of the Clinical Outcomes From Patient Self-management of Antivitamin K Treatment at the Hospitald de Sant Pau. ORION Study

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1 site in 1 country927 target enrollmentStarted: November 1, 2017Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
927
Locations
1
Primary Endpoint
Thromboembolic events

Study Overview

Brief Summary

ORION is a retrospective, observational, one center study to evaluate the incidence of complications (both thromboembolic and bleedings) in a cohort of patients receiving Vitamin K antagonists (VKA) under a self-management program, since 2002 at the Hospital de la Santa Creu i Sant Pau in Barcelona (Spain)

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adult patients (older than 18) under chronic VKA treatment, whom performed patient self-management for any indication of oral anticoagulation.
  • •Signed informed consent

Exclusion Criteria

  • •Patients younger than 18 years old

Outcomes

Primary Outcomes

Thromboembolic events

Time Frame: since 1 of july of 2002 to 30th of june of 2018

Any documented embolic stroke, peripheral arterial embolism or venous thromboembolism

Major hemorrhagic event

Time Frame: since 1 of july of 2002 to 30th of june of 2018

Any documented bleeding event grade 3 or 5 in the Bleeding Assessment Research Consortium (BARC) scale

Secondary Outcomes

  • Mortality(since 1 of july of 2002 to 30th of june of 2018)

Investigators

Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials